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Abstract: National UK standards for critical care highlight the need for clinical pharmacists to
practice at an advanced level and above. The aim of this research paper was to describe the views of
UK critical care pharmacists on the current provision of Advanced Level Practice (ALP) education
and accreditation. It sought to identify whether there is a need for a national or regional training
programme. A questionnaire was delivered electronically targeting UK critical care pharmacists.
Whilst the response rate was low at 40% (166/411); the views expressed were representative of
UK practitioners with the majority of responders meeting the national specifications for clinical
pharmacist staffing in critical care areas. The responses highlighted work-based learning as the
main resource for developing ALP and a lack of suitable training packages. The vast majority
of pharmacists identified that a national or regional training programme was required for ALP.
The results also identified the main barriers to undertaking ALP accreditation were lack of time,
uncertainty regarding the process and its professional benefits and a lack of education and training
opportunities. In conclusion, the responses clearly indicated that, for the necessary progression of
critical care pharmacists to ALP, a national or regional training programme is required.
Keywords: advanced practice; pharmacy; education
1. Introduction
In the UK, specialist pharmacists working in critical care have started to engage in the process
of developing Advanced Level Practice (ALP). A competency framework for ALP in critical care
pharmacy was developed by the United Kingdom Clinical Pharmacy Association Critical Care Group
(UKCPA CCG) in 2003 [1]. This was underpinned by a syllabus of knowledge required for pharmacists
practicing in critical care, and, subsequently, a credentialling process was developed to assess this [2,3].
The process from devising the competency framework to the credentialling process has provided the
basis for assessment of ALP in critical care within the newly formed Royal Pharmaceutical Society
(RPS) Faculty [4].
The UK national standards for critical care include recommendations on the skill level and
staffing requirements for critical care pharmacists [5]. The standards emphasise the need for critical
care pharmacists to be working at ALP (Band 8a) or consultant level (Band 8b+) [5]. It indicates that
pharmacists working at critical care foundation level (equivalent to Faculty Advanced Stage I (MFRPSI))
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should have access to colleagues at critical care advanced level (equivalent to Faculty Advanced Stage
II (MFRPSII)) or consultant level (Faculty Fellow (FFRPS)) for advice and referrals [2,4,5]. This is
particularly important when dealing with the highly complex patients common to critical care practice.
Currently, the UK critical care workforce data identifies that approximately half of the pharmacists feel
they are working at, or below critical care foundation level. Additionally, 24.8% of NHS Trusts have
a critical care pharmacy service delivered at foundation level or below [6].
There are currently no UK-based formalised training programmes that meet the needs of
pharmacists seeking to develop the skills for critical care ALP framework. The scenario is similar in
the US, where the training capability of specialist critical care pharmacists has been recognised as
a major limitation to nationwide implementation of this clinical service [7]. The American College of
Clinical Pharmacy (ACCP) also recognise that education and training is essential for the development
of advanced pharmacists’ roles [8].
For the UK to deliver the necessary critical care pharmacist workforce capacity at ALP and
above, an education strategy linked to workforce development is required. It is therefore important
to establish the educational resources that are currently being used by critical care pharmacists. This
is to ensure that their clinical practice is supported as they advance through the critical care ALP
framework. Their perspective on the current resources and their opinion on the need for a national
educational programme specifically developed for ALP in critical care pharmacy are required.
The aim of the questionnaire was to describe the views of UK critical care pharmacists on the
current provision of ALP education including the UKCPA CCG’s masterclass study days. It also
sought to identify the thoughts of pharmacists on the perceived need for a national or regional training
programme for ALP.
2. Methodology
A prototype of the questionnaire was designed and presented to the UKCPA CCG Expert
Practice Development Group1 who commented extensively. It was redesigned and the final version
(Appendix 1) was delivered electronically using Survey Monkey®. A link was posted on the UKCPA
CCG discussion board with subsequent reminder postings.
The questionnaire was also circulated via email to critical care pharmacists within the UK to
ensure those who were not members of the UKCPA were also surveyed. The questionnaire was closed
in May 2015 and analysis began in June 2015. The survey was classified as a service evaluation by the
Sheffield Teaching Hospitals NHS Foundation Trust Clinical Effectiveness Unit (CEU number: 6853).
Sub-group analysis was performed according to the status results for whether the pharmacists
worked in a designated teaching hospital, as part of a critical care pharmacy team and also whether
they had already undertaken the UKCPA credentialing or RPS faculty assessment. A Chi-square
analysis (with Yates correction for continuity) was used to compare result proportions between these
sub-groups, and statistical analysis was undertaken using Sigmaplot 12 software (Systat Software Inc.,
San Jose, CA, USA).
3. Results
3.1. Response Rate
A total of 166 critical care pharmacists completed the questionnaire out of a potential 411 practicing
within the UK at the current time. Thus, we had a response rate of approximately 40%.
1 The UKCPA CCG Expert Practice Development Group is comprised of UK pharmacists working at advanced or
consultant-level practice in critical care pharmacy who lead the development of pharmacy practice and research in
this specialty.
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3.2. Pharmacist Demographics
There was representation from throughout the UK; 82.6% (128/155) from England, 6.5% (10/155)
from Scotland, 7.1% (11/155) from Wales and 3.9% (6/155) from Northern Ireland. 50.9% (84/165) of
pharmacy responders had worked in critical care for 5 years or more and 31.5% (52/165) had worked
for 2–5 years. A total of 83.4% (136/163) were Band 8a and above (Table 1). Approximately three-fifths
(59.8%, 98/164) worked in a designated teaching hospital and three-quarters (74.4%, 122/164) worked
as part of a critical care pharmacy team.
Table 1. Agenda for Change (AfC) Banding of pharmacist responders.
Afc Band Frequency, n (%)
6 1 (0.6%)
7 26 (16%)
8a 106 (65%)
8b 26 (16%)
8c 4 (2.5%)
Note: Pharmacists entry level into the NHS is AfC Band 6 with potential progression up to AfC Band 8c or d
within clinical practice.
3.3. UKCPA Credentialing and RPS Faculty Accreditation
Out of the 166 critical care pharmacists, 21 (12.8%) had undertaken the UKCPA credentialing or
RPS Faculty accreditation. Pharmacists working in a designated teaching hospital appeared more
likely to have undertaken the UKCPA credentialing or RPS faculty accreditation compared to those
who did not, 17.3% (17/98) compared to 6% (4/66). However, this difference in proportions did not
reach statistical significance (p = 0.06).
Critical care pharmacists identified potential barriers for undertaking the UKCPA credentialing
or RPS Faculty accreditation; two-fifths (42.2%, 57/135) were unsure what the process involved and
approximately a quarter (23.7%, 32/135) were unsure of its professional benefits (Figure 1). In addition,
more than one-third of respondents (37%, 50/135) felt that there was a lack of regional or national
education and training opportunties for developing ALP (Figure 1). Interestingly, only 5.2% (7/135)
felt that they were not interested in pursuing ALP from a career perspective (Figure 1).
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3.4. Educational Resources used for Preparation for Advanced Level Practice
Pharmacists reported using a wide range of educational resources to develop ALP (Figure 2).
In particular, they rely on “on the job training”, multidisciplinary ward rounds and journal clubs
or reading journals (Figure 2). The UKCPA Advanced Masterclasses were also well accessed by
pharmacist responders (76.5%, 98/128) with good perceived benefit (57.1%, 56/98 reported them to be
very useful) (Figure 2).
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Figure 2. Percentage of critical care pharmacists using particular educational resources to develop
their advanced level practice. * European Society of Intensive Care Medicine (ESICM), Intensive
Care Society (ICS), International Symposium on Intensive Care and Emergency Medicine (ISICEM);
** ESICM, Association of Anaesthetists of Great Britain and Ireland (AAGBI), Society of Critical Care
edicine (S ).
Just over a quarter (28.6%, 36/126) of pharmacist responders reported using a local or regional
training package (Figure 2). The majority (80%, 8/10) that then commented, stated they used the
Midlands Critical Care Networks (MCCN) Band 7 pharmacist training pack, which is only suitable for
developing foundation level practice [9]. Others (20%, 2/10) stated that they used in-house training
packages some of which were designed for nurses or anaesthetists.
Pharmacist responders had divided views on whether the current educational resources were
adequate for developing ALP. Overall, most disagreed or strongly disagreed (46.7%, 64/137) that the
educational resources were adequate, with 40% (55/137) being unsure.
3.5. National or Regional Training Programme for Advanced Level Practice
Overall, 89.8% (123/137) of the pharmacist responders agreed (50.4%, 69/137) or strongly agreed
(39.4%, 54/137) that there was a need for a national or regional training programme for ALP in
critical care. In addition, all the pharmacists who had undertaken the UKCPA credentialing process or
RPS faculty accreditation felt this was needed (100%, 20/20; 9/20 agreed and 11/20 strongly agreed,
1 declined to answer). There was no difference between the pharmacists who had been assessed
for ALP and the non-assessed group in the proportions supporting the development of a training
programme (p = 0.217). There was also no difference in the views of pharmacists who worked in a
designated teaching hospital or who worked as part of critical care pharmacy team compared to those
that did not (p = 0.462 and p = 1.00, respectively).
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3.6. UKCPA CCG Masterclasses
The UKCPA CCG currently run two different masterclasses “starting out in critical care”
for pharmacists beginning to work in critical care and “advanced practitioner”. The “advanced
practitioner” day covers different topics suited to pharmacists working towards or at an advanced
level. Approximately four-fifths (78.1%, 107/137) of pharmacist responders had attended at least one
UKCPA critical care masterclass with 41.6% (57/137) attending both the “starting out in critical care”
and “advanced practitioner” days. Pharmacists identified both benefits and barriers to a critical care
conference over the current masterclass system (Table 2).
Table 2. Benefits and barriers of a critical care conference over current masterclass study days.
Benefits or Barriers of a Critical Care Conference Frequency n, (%)
Networking, e.g., discussing with peers, sharing best practice and providing advice (Benefit) 110 (84%)
Potential for more topics to be included (Benefit) 103 (79%)
Inclusion of different levels, e.g., beginners, foundation & advanced level (Benefit) 98 (75%)
Potential of a more flexible format (ability to choose sessions of interest to attend) (Benefit) 96 (73%)
Conference fees (Barrier) 92 (70%)
Accommodation costs (Barrier) 75 (57%)
Difficulty obtaining managers permission to attend due to increased number of days (Barrier) 75 (57%)
Difficulty in more than one member of your team being able to attend (Barrier) 69 (53%)
Ward cover would not be provided whilst away (Barrier) 65 (50%)
No barriers to a critical care conference 4 (3%)
No advantages to a critical care conference 2 (2%)
The respondents were asked about their preferences for the format of a critical care conference.
The majority (61.2%, 79/129) preferred the option of a mixture of different ability sessions (beginners
and advanced level sessions) running simultaneously each day rather than specific days for different
levels of practice (e.g., Day 1: Beginner, Day 2: Advanced and Expert). Comments from respondents
highlighted that the mixed ability sessions would allow increased networking, learning from peers
and experts and tailoring of attendance to their own learning needs. Approximately two-thirds of
respondents (66.7%, 86/129) were interested in having a third day for the clinical assessment of the
RPS faculty accreditation.
Overall, pharmacists felt that a critical care conference was better for critical care education
than the current masterclass days, and 98.5% (129/131) suggested that they would be interested in
attending this.
4. Discussion
To our knowledge, this is the first questionnaire conducted to obtain the views of UK critical
care pharmacists regarding the provision of ALP education. Although the response rate was only
40%, we received representative responses throughout the UK with the views of both UKCPA and
non-UKCPA members surveyed. The majority of pharmacists had worked in critical care for more than
two years and were Band 8a and above. Hence, they are representative of the national specifications
for clinical pharmacist staffing in critical care areas.
The most important finding was that almost all (circa 90%) respondents indicated that they
believed a national training package for ALP was required in this pharmacy specialty. This is a clear
indication that such a training programme must be developed if the profession is to be able to provide
the adequate numbers and level of clinical pharmacists stipulated by the national standards for critical
care [5]. Every critical care patient should be reviewed by an advanced level critical care pharmacist;
if not, the clinical pharmacist should have access to advice from an advanced level pharmacist. The
importance of having input from a senior or consultant-level critical care pharmacist was highlighted
by the PROTECTED UK study, which identified that they provided a higher level of care [10].
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Currently, the main resources critical care pharmacists used to develop their ALP were “on the job”
learning and attendance of multidisciplinary ward rounds. Work-based learning or apprenticeships can
be restrictive in their provision of professional development opportunities [11]. In addition, work-based
learning has been reported to be insufficient in preparing doctors for the transition to specialist training
in a timely manner, under the restrictions of the European working time directives [12]. A reliance on
work-based learning by critical care pharmacists may not be an efficient or sufficient way to develop
ALP. To accelerate the progression of ALP, critical care pharmacists need more appropriate and targeted
educational resources.
The demographics of the respondents suggest that a significant proportion of critical care
pharmacists are at a suitable level to undertake the RPS faculty accreditation for Advanced Stage
II. Importantly, only a small minority were uninterested in pursuing this from a career perspective.
This indicates a large proportion of critical care pharmacists do want to obtain ALP. Interestingly,
a significant number of respondents were unsure what the RPS Faculty accreditation process involved
and its professional benefits. The RPS may need to address critical care pharmacists’ awareness of the
Faculty and its potential benefits. Critical care pharmacists did consider that they were not confident
to self-assess their level of clinical practice and identified this as a barrier to undertaking the RPS
Faculty accreditation. The literature does support that self-assessment by health professionals is
usually poor [13]. In addition, the participants’ feedback from the UKCPA credentialing suggested that
undertaking this process increased their confidence in self-assessment but they also highlighted the
need for peer review, formal education and guidance [14]. There were divided opinons on whether the
current educational resources were adequate for pharmacists to develop their practice to an advanced
level. However, a lack of resources was cited as a barrier to undertaking the RPS faculty accreditation.
Comments from the respondents suggested that the provision and access to resources may be affected
by locality and that pharmacists working in isolation may be at a disadvantage. A national training
programme would go some way to address this imbalance. Furthermore, to overcome some of the
barriers identified by the pharmacists to undertaking RPS faculty accreditation, any national training
programme should incorporate a way for pharmacists to measure their level of practice against the
critical care syllabus. Considering the importance of providing the appropriate level of pharmaceutical
care to critically unwell patients, the support of the NHS should be sought to help deliver this.
There was minimal use of critical care e-learning packages, web courses or tutorials. The HeXL
study has identified many challenges of adopting e-learning amongst NHS healthcare professionals
including; its suitability, learner awareness, availability and users learning preferences [15]. However,
e-learning has been shown to increase user access and allow more flexible learning [16]. There is great
potential for the use of e-learning for critical care pharmacists and it would be important to identify
the reasons why it is not being used currently.
Some respondents stated that they use other resources such as British Association for Parenteral
and Enteral Nutrition (BAPEN), The European Society for Clinical Nutrition and Metabolism (ESPEN),
and The British Society Antimicrobial Chemotherapy (BSAC). This highlights the potential importance
for cross over with education and training of other UKCPA clinical specialties. The current UKCPA
masterclasses are useful in developing critical care pharmacists’ practice. However, a critical care
conference may provide one way to improve the education and training provision for ALP and perhaps
complement a national training programme. The critical care pharmacists are supportive of developing
a critical care conference.
In summary, the results of this questionnaire have highlighted the inadequate provision of ALP
training in UK critical care pharmacy. The NHS should work with current training organisations such
as the UKCPA and RPS to ensure this is delivered to support the care of critically ill patients.
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Limitations
Not all critical care pharmacists’ views in the UK have been identified as at least half of the critical
care pharmacists in the UK did not respond. In addition, not all of the critical care pharmacists may
have received the survey, as we tried to target all of them, but some were contacted through surrogates.
Not all questions were answered by all of the respondents including some of the baseline
characteristics. For instance, 6.6% (11/166) did not respond to the question of which country they
practice in within the UK. It is possible that some of the pharmacists do not currently work in the UK
as the UKCPA website is also used by pharmacists worldwide.
Pharmacists were asked if they worked as part of a critical care pharmacy team. However, we
did not explain explicitly what we meant by a “critical care pharmacy team”; for example, this did
not allow us to differentiate the different staff skill mix (pharmacists banding, medicine management
technicians) and the size of their team.
The questionnaire did not establish the critical care pharmacists’ thoughts on specific gaps in
the provision of teaching for certain elements of knowledge or skills related to UKCPA critical care
syllabus. Further work should be carried out to identify these gaps to allow more targeted education
and training for critical care pharmacists.
5. Conclusions
This questionnaire of UK critical care pharmacist opinions on education for developing ALP
represented views from the across the UK. The results highlight that currently there are no suitable
training packages for ALP and that inefficient work-based learning is the main resource currently used
by critical care pharmacists.
To accelerate the progression of critical care pharmacists to ALP in the numbers required nationally,
more appropriate and targeted educational resources are required. There is a need for a national or
regional training programme to be developed for ALP, and UK critical care pharmacists are supportive
of this.
Further research is required to identify an effective education and training model for ALP within
critical care. The potential for cross specialty education and training should be explored within
this model.
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Appendix A
The Advanced Level Practice education questionnaire;
1. Please indicate your UK country of practice.
a England
b Scotland
c Wales
d Northern Ireland
2. How many years of experience do you have working in critical care?
0–2 years, >2–5 years, >5–10 years, >10 years
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3. Please indicate your posts AFC band:
6
7
8a
8b
8c
8d
9
4. Do you work in a designated teaching hospital?
Yes
No
5. Do you routinely work as part of a critical care pharmacy team?
Yes
No
6. Have you previously undertaken either the UKCPA Critical Care Group credentialing process or
the Royal Pharmaceutical Society Faculty assessment?
Yes
No
7. What are the important barriers for not undertaking the UKCPA CCG credentialing or RPS
Faculty assessment? Select all that apply;
Select
Do not believe I am currently at an appropriate level to undertake
Financial burden excessive
Lack ability to assess my current level of practice
Lack of educational and training opportunities/facilities regionally or nationally available
for advanced level practice
Not enough time to prepare for
Not interested in pursuing from a career perspective
Uncertain what the UKCPA credentialing process or RPS Faculty assessment involves
Unsure of the professional benefits to me
Comments;
8. What educational resources do you use to develop your advanced level practice? For those that
you use, rate how useful you find them.
Where 1 is not useful and 5 is very useful
1 2 3 4 5 Do Not Use
Attendance of multidisciplinary ward rounds
CPPE learning packages
e-learning—critical care-related areas
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ESICM/ AAGBI/ SCCM webcourses/tutorials (or
equivalent), e.g., PACT/learnicu.org
Journal clubs (e.g., local or UKCPA CCG) or regular review
and reading of critical care-related journals
Local medical education meetings (e.g., Postgraduate
Medical Education)
Local pharmacy educational meetings
Local/ regional training package (Please state origin & level
in the comments box)
National or international critical care-related conferences, e.g.,
ICS, ESICM, SCCM, ISICEM meetings
On the job learning
Other health professional study days/conferences (Please
state organisation in comments box)
Postgraduate qualification (e.g., MSc in critical care)
Regional or network-wide pharmacy educational meetings
Royal Pharmaceutical Society webinars
UKCPA Advanced Masterclasses
UKCPA Symposiums
Visits to other units to observe other critical care
pharmacists practice
Others (Please state in comments box)
Comments;
9. The current educational resources available are adequate for developing advanced level practice
and for the preparation for the credentialing process.
Strongly disagree, disagree, neither disagree or agree, agree, strongly agree
Comments;
10. There is a need for National or regional training programmes for critical care advance level
practice
Strongly disagree, disagree, neither disagree or agree, agree, strongly agree
Comments;
11. Have you ever attended a UKCPA critical care masterclass?
No
Yes—“starting out” only
Yes—advanced practitioner only
Yes—both “starting out” and advanced practitioner
The UKCPA CCG is considering holding a critical care conference incorporating the material
from the masterclass study days delivered over 2 consecutive days with a 3rd day for pre-registered
candidates to undergo assessment for RPS Faculty accreditation.
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12. What benefits do you think a critical care conference would provide over the current system of
beginner and advanced masterclasses study days?
Select all that apply;
Select
Networking, e.g., discussing with peers, sharing best practice and providing advice
Potential for more topics to be included
Potential of a more flexible format (Ability to choose sessions of interest to attend)
Inclusion of different levels, e.g., beginners, foundation & advanced level
Other (Please state in comments box)
None
Comments;
13. What barriers may prevent you from attending a critical care conference over the current
masterclass study day system?
Select all that apply;
Select
Conference fees
Accommodation costs
Ward cover would not be provided whilst away
Difficulty obtaining managers permission to attend due to increased number of study days
Difficulty in more than one member of your team being able to attend
Other (Please state in comments box)
None
Comments;
14. Two different formats have been suggested for the critical care UKCPA conference. Please select
the format you would prefer;
a Specific conference day designated for different level of practice (e.g., Day 1: Beginner, Day
2: Advanced and Expert)
b Mixture of different ability sessions each day (e.g., beginners and advanced level sessions
running simultaneously)
Comments;
15. Would you be interested in attending a 3rd Day in which you were assessed for RPS
Faculty accreditation?
Yes
No
16. Where do you think the RPS Faculty assessment would be best placed in relation
tothe conference?
a Day before the conference
b Day after the conference
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17. What would you be willing to pay for a UKCPA critical care conference fees/ day (if not fully or
partially funded by your employer)?
a £50–100
b >£100–150
c >£150–200
d >£200–250
18. A UKCPA critical care conference run over 2 days would be a better way to provide critical care
education over the current masterclass study days.
Strongly disagree, disagree, neither disagree nor agree, agree, strongly agree
Comments;
19. Would you be interested in attending a Critical Care UKCPA conference?
Yes
No
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